These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
723 related articles for article (PubMed ID: 31132609)
21. pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. Zhang S; Guo N; Wan G; Zhang T; Li C; Wang Y; Wang Y; Liu Y J Nanobiotechnology; 2019 Oct; 17(1):109. PubMed ID: 31623608 [TBL] [Abstract][Full Text] [Related]
22. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
23. Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers. Huang W; Lang Y; Hakeem A; Lei Y; Gan L; Yang X Int J Nanomedicine; 2018; 13():1723-1736. PubMed ID: 29606866 [TBL] [Abstract][Full Text] [Related]
24. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
25. Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy. Li X; Jia X; Niu H Int J Nanomedicine; 2018; 13():4107-4119. PubMed ID: 30034236 [TBL] [Abstract][Full Text] [Related]
26. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy. Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753 [TBL] [Abstract][Full Text] [Related]
27. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367 [TBL] [Abstract][Full Text] [Related]
28. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer. Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174 [TBL] [Abstract][Full Text] [Related]
29. Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer. Shen H; Li F; Wang D; Yang Z; Yao C; Ye Y; Wang X Drug Des Devel Ther; 2018; 12():921-934. PubMed ID: 29719378 [TBL] [Abstract][Full Text] [Related]
30. Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition. Yang C; Qin Y; Tu K; Xu C; Li Z; Zhang Z Colloids Surf B Biointerfaces; 2018 Sep; 169():10-19. PubMed ID: 29747026 [TBL] [Abstract][Full Text] [Related]
31. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells. Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477 [TBL] [Abstract][Full Text] [Related]
32. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related]
33. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132 [TBL] [Abstract][Full Text] [Related]
34. Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer. Zeng X; Cheng X; Zheng Y; Yan G; Wang X; Wang J; Tang R Carbohydr Polym; 2020 Jun; 237():116139. PubMed ID: 32241443 [TBL] [Abstract][Full Text] [Related]
35. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
36. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. Wong HL; Bendayan R; Rauth AM; Wu XY J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178 [TBL] [Abstract][Full Text] [Related]
38. pH sensitive liposomes delivering tariquidar and doxorubicin to overcome multidrug resistance of resistant ovarian cancer cells. Xia Y; Fang M; Dong J; Xu C; Liao Z; Ning P; Zeng Q Colloids Surf B Biointerfaces; 2018 Oct; 170():514-520. PubMed ID: 29960952 [TBL] [Abstract][Full Text] [Related]
39. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging. Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307 [TBL] [Abstract][Full Text] [Related]
40. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. Lee ES; Na K; Bae YH J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]